1. Home
  2. NNNN vs ATAI Comparison

NNNN vs ATAI Comparison

Compare NNNN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$27.70

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.14

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
ATAI
Founded
2021
2018
Country
Germany
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
NNNN
ATAI
Price
$27.70
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.00
AVG Volume (30 Days)
26.9K
3.6M
Earning Date
04-28-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$8,185,146.00
$3,018,000.00
Revenue This Year
N/A
$943.83
Revenue Next Year
N/A
N/A
P/E Ratio
$534.57
N/A
Revenue Growth
21.95
811.78
52 Week Low
$5.18
$1.15
52 Week High
$55.65
$6.75

Technical Indicators

Market Signals
Indicator
NNNN
ATAI
Relative Strength Index (RSI) 48.35 44.63
Support Level $26.89 $4.25
Resistance Level $44.73 $4.63
Average True Range (ATR) 5.78 0.22
MACD -0.21 0.08
Stochastic Oscillator 29.62 52.91

Price Performance

Historical Comparison
NNNN
ATAI

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Share on Social Networks: